Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lazard, Inc. filings on SEC EDGAR ↗
Lazard M&A Deal with Campbell Lutyens Holdings Limited
Lazard, Inc. filed a prospectus supplement to facilitate the potential resale of up to 9,416,817 shares of common stock by selling stockholders. These shares were previously issued as consideration for Lazard's acquisition of 100% of Campbell Lutyens Holdings Limited. The filing serves to register these shares for secondary sale, and Lazard will receive no proceeds from any such sales.
Lazard Signs $742M M&A Deal with Campbell Lutyens Holdings Limited
Lazard completed its acquisition of Campbell Lutyens, launching a new global private capital advisory business called Lazard CL. The total consideration includes approximately $448.8 million in initial equity (9.65 million shares at $46.50), $93.2 million in initial cash, $115 million in deferred consideration, and up to $85 million in contingent earn-outs.
Value
$742M
Counterparty
Campbell Lutyens Holdings Limited
“We are thrilled to launch our third global business, Lazard CL. By pairing leading global positions in primary fundraising and secondary advisory with our world-class M&A, capital markets, and restructuring expertise, we are deepening the connectivity between our advisory businesses and strengthening our reach across both the largest strategic transactions and private capital activity.”